Skip to content

Mesa Laboratories

US · MLAB #3485 by market cap
127.93 -5.48 -4.11%
Periodic snapshot; not a real-time feed. · 2026-11-20 19:30

Price chart

Pre-market 131.71 -1.27%
After-hours 127.93 0.00%
142.2390.55127.932026-05-262026-11-20
MA5MA10MA20MA60
— MA5 — MA10 — MA20 — MA60
Reader sentiment Are you bullish or bearish on MLAB?

Anonymous reader poll. Unscientific, not investment advice.

✦ StockVane Quant Insights how this is computed

Quant Sentiment Bullish
  • Recent price momentum is +43.7% on average (3-month/1-year).
  • Main-fund capital flow has been a net inflow over the last 45 sessions.
  • Short interest has risen to 6.7% of float.
  • Analyst tilt is Buy.
Quant Technical Outlook Neutral
  • Price is below its 20-day average and below its 60-day average.
  • The 20-day average is above the 60-day average, a short-term uptrend.
Quant Rating, last 30 days B → C

Computed by a StockVane algorithm from historical price, valuation and analyst data - not a person, not a forecast guarantee, and not investment advice.

Factor grades

Ranked against 2848 U.S. stocks StockVane covers.

Last computed: 2026-11-22 08:27 UTC

Data coverage: 5 of 6 factors. Missing data is not a zero score.

Overall B

The radar needs all six factors. Available grades are shown below.

Valuation D

How expensive the stock is versus earnings, sales and its own 5-year history.

P/E (TTM) 110.3x Better than 3%
Forward P/E 53.3x Better than 7%
Price / Sales 3.1x Better than 40%
P/E vs own 5-yr range 59th pctl Better than 50%
Growth A-

How fast revenue, profit and free cash flow are compounding.

Revenue CAGR (3Y) 4.4% Better than 44%
Net income CAGR (3Y) 93.3% Better than 95%
Free cash flow CAGR (3Y) 19.1% Better than 63%
Profitability C+

How much profit the business keeps from each dollar of sales and capital.

Gross margin 63.5% Better than 77%
Operating margin 7.4% Better than 43%
Net margin 2.7% Better than 35%
Return on equity 3.9% Better than 34%
Return on invested capital 3.8% Better than 40%
Momentum A

Recent price strength, skipping the latest month to avoid short-term noise.

3-month return 2.7% Better than 79%
6-month return 18.1% Better than 81%
12-month return (ex latest month) 83.4% Better than 93%
Distance below 52-week high 11.4% Better than 80%
Financial Health B-

Balance-sheet strength: leverage, liquidity and interest coverage.

Current ratio 1.7x Better than 48%
Debt to assets 36.3% Better than 31%
Interest coverage 2.1x Better than 37%
Free cash flow / net income 589.7% Better than 94%
Analyst View N/A

What the Street thinks: share of Buy ratings and upside to the average target.

Not enough data to grade this factor.

Grades are relative rankings, not forecasts: A+ is the top 5% of the covered stocks on a factor, F the bottom 3%. Valuation is not adjusted for sector. Background recomputation is scheduled every 6 hours; actual computation time is shown above, and source datasets have different reporting dates. Not investment advice or tailored to your financial situation.

Performance

1W -7.97%
1M +2.21%
3M +7.50%
6M +23.35%
YTD +63.70%
1Y +79.83%
3Y +45.94%
5Y -57.97%

Key statistics

Price & volume

Prev close
133.41
Open
131.62
Day range
126.73 - 134.00
Avg price
129.98
Volume
76.02K
Turnover
9.88M
Amplitude
5.45%
52-week range
69.73 - 144.35

Valuation

P/E
105.73
P/E (TTM)
110.28
P/B
3.70
EPS
1.21
Net profit
6.80M
Net assets
194.59M

Share structure

Market cap
719.03M
Float cap
635.59M
Shares out
5.62M

Dividend & listing

Dividend (TTM)
0.64
Listing date
--
52-week range 78% of range
69.73 144.35

11.4% below the 52-week high

Trading activity

Net capital flow main funds, last 45 sessions

+630.11K net over the window

Short interest

Shares short
377.16K
As of
2026-10-30

Frequently asked questions

What is the current stock price of Mesa Laboratories (MLAB)?

Mesa Laboratories last traded at 127.93. This page shows a periodic quote snapshot. Check the displayed quote time.

What is Mesa Laboratories's market cap?

About 719.03M.

What is the P/E ratio of Mesa Laboratories?

The trailing twelve-month P/E is 110.28. The Valuation tab shows it against the stock's own five-year range.

Does Mesa Laboratories pay a dividend?

Yes. The trailing dividend yield is 0.50%. Per-share dividends have risen or held for 7 straight years through 2025. See the Dividends tab for the full payment history.

Is Mesa Laboratories a buy according to analysts?

The consensus of 1 analysts is a Buy rating, with an average 12-month price target of 150.00, which implies 17.3% upside from the current price. This is not investment advice.

What is Mesa Laboratories's StockVane Quant Rating?

The StockVane Momentum strategy currently rates Mesa Laboratories a C (Hold). Mid-pack momentum — held if you own it, not a fresh buy. Not investment advice.

Quote time 2026-11-20 19:30:05 · For reference only, not investment advice and not tailored to your situation.

Mesa Laboratories discussion 0 comments

Add a comment